HCG

HCG 1000 IU research peptide is a purified form of human chorionic gonadotropin (hCG), a glycoprotein hormone widely studied for its role in reproductive signaling and LH/CG receptor activation. In laboratory settings, hCG is commonly used as a model ligand for investigating receptor-mediated steroidogenesis, intracellular signaling cascades, and hormone-dependent cellular responses across endocrine and reproductive biology systems. Because hCG binds the luteinizing hormone/chorionic gonadotropin receptor (LHCGR), it remains a central research tool for studying gonadotropin signaling, ligand-receptor specificity, and downstream biological activity.

Research interest in HCG 1000 IU research peptide centers on receptor activation, cAMP/PKA-linked signaling, steroidogenic output, and hormone-regulated cellular communication. hCG is also studied for its broader biological roles in angiogenesis, endometrial interaction, and immunoregulatory processes at the maternal-fetal interface. These features make it highly relevant in research models focused on implantation biology, corpus luteum support pathways, trophoblast-endometrial signaling, and comparative gonadotropin pharmacology (Nwabuobi et al., 2017 — hCG: Biological Functions and Clinical Applications).

(Tsampalas et al., 2010 — Human Reproduction Update).

Current research applications for HCG 1000 IU research peptide include LHCGR signaling studies, steroidogenesis models, reproductive endocrinology assays, receptor-binding investigations, and glycoprotein hormone structure-function analysis. Researchers also use hCG in experimental systems to compare ligand-specific signaling differences between LH and hCG and to explore how glycosylation state may influence hormone stability, receptor selectivity, and biological response. As a result, hCG remains one of the best-characterized gonadotropin tools in endocrine and reproductive laboratory research (Casarini et al., 2018 — Two Hormones for One Receptor).

The peptide is supplied as a lyophilized powder to ensure optimal stability during storage and handling. COA included with every order. See also: HCG 2000 IU, Tirzepatide, Semaglutide

hCG has long been a central molecule in reproductive biology research because it provides a clear experimental handle on LHCGR-mediated signaling. Historically, hCG preparations were obtained from biological sources, but recombinant production has enabled more standardized material for mechanistic studies, assay development, and comparative structure–function research.

LHCGR signaling and tissue responses

hCG binds the luteinizing hormone/chorionic gonadotropin receptor (LHCGR), triggering intracellular signaling that can influence steroidogenic activity, cellular differentiation responses, vascular remodeling, and immune-modulatory signaling in reproductive tissues. (if you want, I can add web citations properly after a web lookup)

Endometrial receptivity pathways

Experimental work has linked hCG exposure to changes in gene/miRNA networks that affect epithelial cell behavior and implantation-relevant signaling cascades (e.g., PI3K/Akt-related axes) in model systems.

Role of glycosylation

A major research focus is how carbohydrate residues on hCG affect receptor activation efficiency and downstream signaling. Classic studies show that altering glycosylation can reduce signaling output even when receptor binding remains relatively preserved, highlighting glycan importance for signal transduction.

Research applications (non-clinical)

Receptor pharmacology assays (LHCGR binding/activity, cAMP readouts)

Reproductive tissue signaling studies (cell models for implantation-associated pathways)

Analytical and diagnostic assay calibration (standard curves and immunoassay development)

Structure–function experiments (glycoform comparison, potency vs signaling bias)

[1] Nwabuobi C, et al. hCG: Biological Functions and Clinical Applications. Int J Mol Sci. 2017;18(10). DOI:10.3390/ijms18102037.

[2] Wang W, et al. Mechanism of hCG in endometrial receptivity via the miR-126-3p/PI3K/Akt/eNOS axis. Kaohsiung J Med Sci. 2023;39(5):468–477. DOI:10.1002/kjm2.12672.

[3] Moyle WR, Bahl OP, März L. Role of carbohydrate of hCG in mechanism of hormone action. J Biol Chem. 1975;250(23):9163–9169.

[4] Talwar GP, et al. Phase I clinical trials with three formulations of anti-hCG vaccine. Contraception. 1990;41(3):301–316. DOI:10.1016/0010-7824(90)90071-3.

[5] Stevens VC. Use of synthetic peptides as immunogens for developing a vaccine against hCG. Ciba Found Symp. 1986;119:200–225. DOI:10.1002/9780470513286.ch12.

Disclaimer

ALL ARTICLES AND PRODUCT INFORMATION PROVIDED ON THIS WEBSITE ARE SOLELY FOR INFORMATION DISSEMINATION AND EDUCATIONAL PURPOSES.

The products offered on this website are intended exclusively for in vitro research purposes. In vitro research (Latin: in glass) is conducted outside a living organism. These products are not medicinal products and not intended for human or veterinary use.

The products are not intended to diagnose, treat, cure, or prevent any disease or medical condition. It is strictly prohibited to administer these products to humans or animals in any form. The purchaser is solely responsible for ensuring compliance with all applicable laws and regulations.